Search results
Novavax (NVAX) Set to Announce Quarterly Earnings on Friday
ETF DAILY NEWS· 10 hours agoNovavax (NASDAQ:NVAX – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Friday, May 10th. Analysts expect the company to announce ...
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation -...
EconoTimes· 5 hours agoThe Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. This EU...
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street...
Motley Fool via Yahoo Finance· 3 hours agoWhereas Moderna and Pfizer/BioNTech raked in tens of billions of dollars in sales from proverbial...
Novavax (NVAX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) possesses the right combination of the two key ingredients for a likely earnings beat...
Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational...
WKRN Nashville· 2 days agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its first quarter ...
CORRECTED-UPDATE 3-Novavax's top shareholder Shah Capital ramps up efforts for board shakeup
Reuters via Yahoo Finance· 3 days agoShah Capital, which currently owns a near 7.5% stake in Novavax and is its third-largest shareholder, reiterated that the company was "undervalued and continues to suffer ...
Shah Capital urges Novavax shareholders to vote against three directors
Reuters via AOL· 3 days ago(Reuters) -Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life Style via AOL· 3 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
An adjuvant made in yeast could lower vaccine cost and boost availability
UC Berkeley NewsCenter· 1 day agoVaccines save lives, as proven during the recent pandemic, but one component of most vaccines —...
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Zacks· 1 week agoFree Report) closed at $4.33, marking a +0.93% move from the previous day. Shares of the vaccine maker have depreciated by 7.74% over the course of the past month, underperforming ...